[go: up one dir, main page]

HK1233174B - Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof - Google Patents

Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof Download PDF

Info

Publication number
HK1233174B
HK1233174B HK17106902.5A HK17106902A HK1233174B HK 1233174 B HK1233174 B HK 1233174B HK 17106902 A HK17106902 A HK 17106902A HK 1233174 B HK1233174 B HK 1233174B
Authority
HK
Hong Kong
Prior art keywords
fibers
seed
bacillus coagulans
coagulans mtcc
amla
Prior art date
Application number
HK17106902.5A
Other languages
German (de)
French (fr)
Chinese (zh)
Other versions
HK1233174A1 (en
Inventor
Sivakumar Arumugam
Furqan Ali
Muhammed Majeed
Original Assignee
Muhammed Majeed
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Muhammed Majeed filed Critical Muhammed Majeed
Publication of HK1233174A1 publication Critical patent/HK1233174A1/en
Publication of HK1233174B publication Critical patent/HK1233174B/en

Links

Description

BACKGROUND OF THE INVENTION FIELD OF THE INVENTION
The invention in general relates to Bacillus coagulans (Lactic acid bacteria). More specifically, the invention relates to (i) the growth promotional activity of natural plant based fibers on Bacillus coagulans MTCC 5856; (ii) The production of short chain fatty acids (SCFA) by Bacillus coagulans MTCC 5856 using plant based natural fibers; and (iii) the combination of natural plant based fibers and Bacillus coagulans MTCC 5856 to inhibit Gram negative pathogenic bacteria.
DESCRIPTION OF PRIOR ART
Combining multistrain probiotics (probiotic bacteria) and prebiotics to achieve enhanced immunosupportive effects is well known in the art. Specifically combining probiotics with natural plant based fibers to formulate synbiotics is reported as a promising therapeutic approach (Stig Bengmark and Robert Martindale. "Prebiotics and Synbiotics in Clinical Medicine". Nutr Clin Pract vol 20 244-261, April 2005). The success of such an approach depends on carefully choosing specific probiotic microorganisms whose viable count is effectively enhanced by natural plant based fibers that are resistant to both enzymatic and acid hydrolysis in the gut. These studies are critically important to accommodate the performance of host animals exposed to symbiotic diet regimes given the teaching that there are limitations to fiber digestion and utilization by microbes in terms of microbial accessibility to substrates, physical and chemical nature of fibers (forage) and also kinetics of the digestive process (Gabriella A. Varga and Eric S. Kolver, "Microbial and Animal Limitations to Fiber Digestion and Utilization", J. Nutr. May 1, 1997 vol. 127 no. 5 819S-823S). Pandey, K. R. et al., J Food Sci Technol., 2015, 52(12), pages 7577 to 7587 disclose health benefits imparted by probiotics and prebiotics as well as synbiotics. Most commonly used probiotic strains are: Bifidobacterium, Lactobacilli, S. boulardii, B. coagulans. Prebiotics like fructooligosaccharide (FOS), galacto-oligosaccharides (GOS), xyloseoligosaccharide (XOS), Inulin; fructans are the most commonly used fibers which when used together with probiotics are termed synbiotics and are able to improve the viability of the probiotics.
It is the principle objective of the present invention to evaluate the performance of selected natural fibers (enzyme and acid hydrolysis resistant) to enhance the viable counts of Bacillus coagulans MTCC 5856.
It is also another objective of the present invention to evaluate the ability of the synbiotic composition (natural fibers and Bacillus coagulans MTCC 5856) to inhibit pathogenic Gram negative bacteria.
It is yet another objective of the present invention to evaluate the ability of the synbiotic composition (natural fibers and Bacillus coagulans MTCC 5856) to produce desired short chain fatty acids, said property having profound therapeutic applications.
The present invention fulfils the aforesaid objectives and provides further related advantages.
SUMMARY OF THE INVENTION
Disclosed is (i) the growth promotional activity of natural plant based fibers on Bacillus coagulans MTCC 5856; (ii) the combination of natural plant based fibers and Bacillus coagulans MTCC 5856 to inhibit Gram negative pathogenic bacteria and (iii) the production of short chain fatty acids (SCFA) by Bacillus coagulans MTCC 5856 using plant based natural fibers.
Other features and advantages of the present invention will become apparent from the following more detailed description, taken in conjunction with the accompanying images, which illustrate, by way of example, the principle of the invention.
BRIEF DESCRIPTION OF THE DRAWINGS
  • Figs. 1a, 1band1c show the graphical representation of the increase in viable colony count of Bacillus coagulans MTCC 5856 in presence of different natural plant fibers alone (%, w/v).
  • Figs. 2a, 2band2c show the graphical representation of the increase in viable colony count of Bacillus coagulans MTCC 5856 in presence of different natural plant fibers (%, w/v) in MRS media (devoid of dextrose) (0.5, 1.0, 2.0%, w/v).
  • Fig. 3 is the graphical representation of inhibition of E. coli ATCC 25922 growth by B. coagulans MTCC 5856 when co-cultured in plant based natural fibers as media. Average mean of viable counts are expressed in log10 cfu/ml.
  • Fig. 4 shows the chromatograph readings for short chain fatty acids.
DESCRIPTION OF THE MOST PREFERRED EMBODIMENTS
In the most preferred embodiment, the present invention relates to a method of increasing the viable colony count of Bacillus coagulans MTCC 5856 said method comprising step of growing Bacillus coagulans MTCC 5856 in the presence of natural plant fibers selected from the group consisting of Trigonella foenum-graecum (fenugreek) seed fibers, Lycium barbarum seed fibers, Linum usitatissimum (Flax) seed fibers, Cocos nucifera (Coconut) fibers, Zingiber officinale (Ginger) rhizome fibers, Emblica officinalis (Amla) fruit fibers, Plantago ovata (Psyllium) fibers and Vaccinium oxycoccos (Cranberry) seed fibers.
In another most preferred embodiment, the present invention relates to a combination of natural plant fibers and Bacillus coagulans MTCC 5856, wherein Bacillus coagulans MTCC 5856 is co-cultured with the natural plant fibers selected from the group consisting of Trigonella foenum-graecum (fenugreek) seed fibers, Lycium barbarum seed fibers, Linum usitatissimum (Flax) seed fibers, Cocos nucifera (Coconut) fibers, Zingiber officinale (Ginger) rhizome fibers, Emblica officinalis (Amla) fruit fibers, Plantago ovata (Psyllium) fibers and Vaccinium oxycoccos (Cranberry) seed fibers for use in the treatment of a subject affected by pathogenic Gram negative bacteria by bringing into contact said Gram negative bacteria with said Bacillus coagulans, wherein said Gram negative bacteria are E. coli.
In yet another most preferred embodiment, the present invention also relates to a method of producing short chain fatty acids by co-culturing Bacillus coagulans MTCC 5856 with natural plant fibers selected from the group consisting of Trigonella foenum-graecum (fenugreek) seed fibers, Lycium barbarum seed fibers, Linum usitatissimum (Flax) seed fibers, Cocos nucifera (Coconut) fibers, Zingiber officinale (Ginger) rhizome fibers, Emblica officinalis (Amla) fruit fibers, Plantago ovata (Psyllium) fibers and Vaccinium oxycoccos (Cranberry) seed fibers. Furthermore, the present disclosure also relates to a method of protecting against diet-induced obesity and insulin resistance in the mammalian gut by administering composition comprising Bacillus coagulans MTCC 5856 with natural plant fibers selected from the group consisting of Trigonella foenum-graecum (fenugreek) seed fibers, Lycium barbarum seed fibers, Linum usitatissimum (Flax) seed fibers, Cocos nucifera (Coconut) fibers, Zingiber officinale (Ginger) rhizome fibers, Emblica officinalis (Amla) fruit fibers, Plantago ovata (Psyllium) fibers and Vaccinium oxycoccos (Cranberry) seed fibers to bring about the effect of protection against diet induced obesity and insulin resistance.
The specific examples included herein below illustrate the aforesaid most preferred embodiments of the present invention.
Example I Method of preparing fibers Trigonellafoenum-graecum (Fenugreek) seed fibers
Trigonella foenum-graecum (also known as Fenugreek) seeds were collected from local market and milled to course powder (10 mesh pass through). Further, four volumes of n-hexane was added to 100 gm of Trigonella foenum-graecum seeds course powder and extracted at reflux temperature. n-Hexane fraction was filtered through Whatman filter no 1 and again three times same extraction was carried out. After extraction, retentate was dried at 80°C for 5 h and then this was milled to obtain 40 mesh pass through powder. In an alternative method, fat or oil from Fenugreek seeds were removed by Super Critical fluid extraction method using liquid CO2 as solvent. To increase the dietary fiber (Galactomannans) content, the enzymatic hydrolysis using Cellulase was carried out. The galactomannans content was determined by Megazyme kit (K-GALM 03/11) as per the manufacturer's instructions (Megazyme International Ireland, Bray Business Park, Bray, Co. Wicklow, IRELAND).
Lycium barbarum seed fibers
Goji, Goji berry or Wolfberry is the fruit of Lycium barbarum. The fruit of Lycium barbarum was dried and seeds were separated and milled to course powder. Further, four volumes of n-hexane was added to 100 gm of Lycium barbarum course powder and extracted at reflux temperature. n-Hexane fraction was filtered through Whatman filter no 1 and again three times same extraction was carried out. After extraction, retentate was dried at 80°C for 5 h and then this was milled to obtain 60 mesh pass through powder. Total dietary fiber was determined by Enzymatic-Gravimetric Method (AOAC 985.29).
Linum usitatissimum (Flax seed) fibers
Linum usitatissimum (also known as common flax or linseed or Flax) seeds were collected and milled to course powder (10 mesh pass through). Further, four volumes of n-hexane was added to 100 gm of Linum usitatissimum course powder and extracted at reflux temperature. n-Hexane fraction was filtered through Whatman filter no 1 and again three times same extraction was carried out. After extraction, retentate was dried at 80°C for 5 h and then this was milled to obtain 40 mesh pass through powder. Total dietary fiber was determined by Enzymatic-Gravimetric Method (AOAC 985.29).
Cocos nucifera fibers
A matured coconut was procured from local market and dried. Further, the endosperm (coconut meat) was chopped to course and uniform size material. Further, four volumes of n-hexane was added to 100 gm of Cocos nucifera course material and extracted at reflux temperature. n-Hexane fraction was filtered through Whatman filter no 1 and again three times same extraction was carried out. After extraction, retentate was dried at 80°C for 5 h and then this was milled to obtain 60 mesh pass through powder. Total dietary fiber was determined by Enzymatic-Gravimetric Method (AOAC 985.29).
Zingiber officinale (ginger) rhizome fibers
Zingiber officinale rhizome, ginger root or simply ginger was dried and milled to course powder (10 mesh pass through). Further, four volumes of n-hexane was added to 100 gm of Zingiber officinale rhizome course powder and extracted at reflux temperature. n-Hexane fraction was filtered through Whatman filter no 1 and again three times same extraction was carried out. In an alternative method, fat or oil from Fenugreek seeds were removed by Super Critical fluid extraction method using liquid CO2 as solvent. After extraction, retentate was dried at 80°C for 5 h and then this was milled to obtain 40 mesh pass through powder. Total dietary fiber was determined by Enzymatic-Gravimetric Method (AOAC 985.29).
Emblica officinalis (Amla) fruit fibers
Emblica officinalis (Phyllanthus emblica), also known as Emblic, Emblic myrobalan, Myrobalan, Indian gooseberry, Malacca tree, or Amla from Sanskrit Amalika. The fruit of Emblica officinalis was procured from local market and dried, pulverized and passed through 60 mesh. This powder was used for the extraction of fibers. Total dietary fiber was determined by Enzymatic-Gravimetric Method (AOAC 985.29).
Example 2-Acid Hydrolysis
Two grams of plant based natural fibers listed in Table 1 were dissolved in 100 ml of HC1 (0.10 M) and incubated at 37°C with 100 rpm for 180 min. Samples were taken at 0, 30, 60, 90, 120 and 180 min. Fructooligosaccharide (FOS; Tata Chemicals, India) was also taken in the study as reference to compare with natural fibers and starch (Potato soluble starch; HiMedia, Mumbai, India) was also taken as control. The increase in reducing carbohydrates was measured by Dinitrosalicylate reagent (Nilsson and Bjorck 1988. Journal of Nutrition 118, 1482-1486). Table 1
Total dietary fiber content of plant based natural fibers
1 65.42±1.2 5.41±0.4 75.24±1.2
2 ND 38.05±0.9 39.71±1.1
3 34.68±0.4 12.73±0.1 50.21±1.5
4 33.16±0.7 36.16±0.2 65.41±1.7
5 ND 41.55±0.7 42.18±0.8
6 10.15±0.2 41.58±0.5 52.07±1.4
  - Soluble Fraction 19.04±0.5 1.527±0.1 22.29±0.4
  - Insoluble Fraction 27.05±0.7 3.55±0.1 33.03±0.7
7 51.13±0.8 30.24±0.8 83.24±1.5
8 10.21±0.6 39.81±07 51.92±1.3
Table 1
ND, Not detected; Total dietary fiber was determined by Enzymatic-Gravimetric Method (AOAC 985.29).
Table 2 shows the effect of acid hydrolysis on (0.1 M HCl; 37°C, 100 rpm) on Plant Based Natural Fibers. Total reducing sugar was determined by Dinitrosalicylic acid (DNSA). Table 2
1 Fenugreek seed fibers 3.79±0.1 3.90±0.1 3.95±0.09 3.33±0.1 4.22±0.2 4.45±0.1
2 11.91±0.2 12.05±0.2 12.98±0.3 11.94±0.4 12.98±0.3 12.51±0.2
3 Flax seed fibers 1.24±0.1 1.89±0.09 1.97±0.1 2.10±0.1 1.98±0.1 2.21±0.1
4 Coconut Fiber 6.11±0.09 6.51±0.2 7.25±0.1 8.35±0.2 9.95±0.2 10.05±0.5
5 Ginger rhizome fibers 4.02±0.1 7.24±0.5 7.98±0.3 8.1±0.7 7.8±0.2 7.5±0.3
6 Amla Fruit Fiber (Soluble + Insoluble) 16.59±0.2 16.14±0.7 16.84±0.3 15.16±0.4 17.12±0.6 16.98±0.6
7 Amla Soluble Fiber 19.96±0.3 24.75±0.5 24.13±0.6 23.42±0.7 22.76±0.8 23.17±0.5
8 Amla Insoluble Fiber 6.98±0.1 6.74±0.1 6.92±0.2 6.95±0.2 7.18±0.1 7.60±0.1
9 Psyllium husk Fiber 0.62±0.01 1.11±0.09 1.28±0.04 1.42±0.1 1.51±0.1 1.62±0.1
10 Cranberry seed Fiber 19.70±0.4 19.15±0.3 20.50±0.9 19.76±0.7 19.67±0.9 20.60±0.8
11 Fructooligosaccharide (FOS) 1.48±0.1 6.29±0.1 8.96±0.1 9.63±0.2 10.47±0.2 12.52±0.4
12 Potato Soluble Starch 7.60±0.2 21.43±0.2 21.03±0.5 25.05±0.7 27.11±0.7 34.20±0.3
Example 3-Enzymatic hydrolysis
100 mg of Pancreatin from Porcine pancreas 4 × USP (Sigma-Aldrich Corporation St. Louis MO, USA) was dissolved in 100 ml of phosphate buffer (50 mM; pH 7.0). Further, plant based natural fibers (2 gm) were dissolved in above Pancreatin solution and incubated at 37°C with 100 rpm for 180 min. Samples were taken at 0, 30, 60, 90, 120 and 180 min. FOS was also taken in the study as reference to compare with plant based natural fibers and starch was also taken as control. The increase in reducing carbohydrates was measured with a Dinitrosalicylate reagent (Oku et al. 1984. Journal of Nutrition 114, 1574-1581). The effect of enzymatic hydrolysis (0.1% Pancreatin in 20mM PBS pH 7.0; 37°C, 100 rpm) on plant based natural fibers is represented in Table 3. Total reducing sugar was determined by Dinitrosalicylic acid (DNSA). Table 3
1 Fenugreek seed fibers 7.20±0.1 8.15±0.1 11.85±0.8 11.35±0.8 10.55±0.1 10.70±0.2
2 11.86±0.2 18.11±0.8 17.85±0.2 17.75±0.4 17.53±0.8 18.21±0.4
3 Flax seed fibers 1.12±0.1 2.56±0.05 2.57±0.1 2.98±0.1 2.78±0.08 2.88±0.04
4 Coconut Fiber 8.85±0.2 11.65±0.2 14.25±0.5 13.60±0.2 10.90±0.4 11.05±0.08
5 Ginger rhizome fibers 4.14±0.09 6.94±0.2 7.12±0.3 7.31±0.4 6.81±0.1 6.82±0.09
6 Amla Fruit Fibers (Soluble + Insoluble) 16.05±0.6 16.94±0.2 16.48±0.2 15.96±0.2 17.40±0.5 16.53±0.7
7 Amla Soluble Fibers 20.10±0.7 22.18±0.8 20.51±0.4 20.90±0.8 23.72±0.8 23.07±0.5
8 Amla Insoluble Fibers 7.12±0.1 7.58±0.3 7.94±0.6 8.19±0.1 8.38±0.01 8.45±0.1
9 Psyllium husk Fiber 1.05±0.1 2.21±0.1 2.26±0.1 2.28±0.02 2.29±0.05 3.07±0.1
10 Cranberry seed Fiber 19.74±0.9 21.99±0.8 24.33±0.3 23.95±0.4 23.58±0.4 23.85±0.7
11 Fructooligosaccharide (FOS) 1.10±0.01 3.37±0.09 3.12±0.09 3.01±0.1 3.43±0.09 3.34±0.08
12 Potato Soluble Starch 7.45±0.05 52.56±0.9 54.06±1.1 52.29±1.2 52.10±1.5 54.52±1.1
Example 4-Growth Promotional activity of Plant Based Natural Fibers with Bacillus coagulans MTCC 5856
Single isolated colony of Bacillus coagulans MTCC 5856 was inoculated into MRS broth (pH 7.0±20; Himedia, Mumbai, India) and incubated at 37°C with 120 rpm for overnight. Plant based natural fibers alone (0.5, 1.0, 2.0%, w/v), and in MRS media (devoid of dextrose) (0.5, 1.0, 2.0%, w/v) were prepared. MRS broth and MRS (devoid of dextrose) were also prepared separately. Similarly, Fructooligosaccharide (FOS) was also taken in the study as reference control to compare with plant based natural fibers. The final pH of all the media was adjusted to 7.0. Five percent of overnight grown Bacillus coagulans MTCC 5856 culture was inoculated to all the flasks and incubated at 37°C with 100 rpm for 24 h. pH values at 0 h of incubation and after fermentation (24 h) were also recorded. Samples were serially diluted in sterile saline and the viable count was enumerated by plating on glucose yeast extract agar (HiMedia, Mumbai, India) at 0 h and after fermentation (24 h). The plates were incubated at 37°C for 48 to 72 h. Each analysis was performed in triplicate at two different occasions. Average mean of viable counts are expressed in log10 cfu/ml. Figs. 1a, 1b and 1c show the graphical representation of the increase in viable colony count of Bacillus coagulans MTCC 5856 in presence of different natural plant fibers alone (%, w/v). Figs. 2a, 2b and 2c show the graphical representation of the increase in viable colony count of Bacillus coagulans MTCC 5856 in presence of different natural plant fibers (%, w/v) in MRS media (devoid of dextrose) (0.5,1.0,2.0%, w/v). In Figs. 1a and 2a "Fenugreek" means "Fenugreek seed fibers", "Lycium" means "Lycium barbarum seed fibers", "Flax" means "Flax seed fibers", and "Coconut" means "Coconut fibers". In Figs. 1b and 2b "Ginger rhizome" means "Ginger rhizome fibers", "Psyllium husk" means "Psyllium husk fiber", and "Cranberry" means "Cranberry fiber". In Figs. 1c and 2c "Amla Fruit" means "Amla fruit fiber", "Amla Soluble" means "Amla soluble fiber", and "Amla Insoluble" means "Amla insoluble fiber". In all of Figs. 1a, 1b, 1c, 2a, 2b and 2c "Viable count" means "B. coagulans MTCC 5856 viable count". In all of Figs. 1a, 1b and 1c "Natural Fibers" means "Plant based natural fibers alone". In all of Figs. 2a, 2b and 2c "Fibers (%, w/v) + MRSD" means "Fibers (%, w/v) + MRS media devoid of Dextrose (MRSD)".
Example 5-Inhibition of E. coli growth
The in-vitro experiment was designed to evaluate the effect of Plant based natural fibers with probiotic bacteria Bacillus coagulans MTCC 5856 for the inhibition of Gram negative pathogenic bacteria E. coli. Briefly, 2.0 g of plant based natural fibers were added to 100 ml of demineralized water. Psyllium husk Fiber and Flax seed fibers were added 0.5 gm to 100 mL of demineralized water due to high gelling property. The pH was adjusted to 7.0±0.2 and autoclaved at 121°C for 20 min. After sterilization, oxygen reducing enzyme Oxyrase (Oxyrase® for Broth, Oxyrase, Inc, Mansfield, OH, USA) was added to each flask. Bacillus coagulans MTCC 5856 was grown on glucose yeast extract agar (Himedia, Mumbai, India) and E. coli ATCC 25922 was grown on trypticase soya agar (Himedia, Mumbai, India). Single isolated colony of both the cultures was used and the turbidity of the bacterial suspension was adjusted to 0.5 McFarland standards (equivalent to 1.5 × 108 colony forming units (CFU)/ml). One milliliter of E. coli ATCC 25922 was added to flask containing plant based natural fiber. Similarly, in other group 1 ml of E. coli ATCC 25922 and 1 ml of B. coagulans MTCC 5856 were added to flask containing plant based natural fiber. The flasks were incubated at 37°C with 100 rpm for 24 h. Samples were serially diluted in sterile saline and the viable count of E. coli ATCC 25922 was enumerated by plating on Eosin Methylene Blue Agar (EMB Agar; HiMedia, Mumbai, India) at 0 h and after fermentation (24 h). The plates were incubated at 37°C for 48 h. Each analysis was performed in triplicate at two different occasions. Average mean of viable counts are expressed in log10 cfu/ml ( Fig. 3 ). In Fig. 3 "Fenugreek" means "Fenugreek seed fibers", "Lycium" means "Lycium barbarum seed fibers", "Flax" means "Flax seed fibers", "Coconut" means "Coconut fiber", "Ginger rhizome" means "Ginger rhizome fibers", "Amla Fruit" means "Amla fruit fiber (soluble + insoluble)", "Amla Soluble" means "Amla soluble fiber", "Amla Insoluble" means "Amla insoluble fiber", "Psyllium husk" means "Psyllium husk fiber", and "Cranberry" means "Cranberry seed fiber".
Example 6-Production of SCFA by Bacillus coagulans MTCC 5856 using Plant Based Natural Fibers
The in vitro fermentation with the Bacillus coagulans MTCC 5856 was carried out by following method described by McBurney and Thompson (McBurney MI and Thompson LU. (1987) Effect of human faecal inoculum on in vitro fermentation variables. Brit J Nutr 58: 233-243) with some modifications. Briefly, 2.0 g of glucose or Plant Based Natural Fibers were added to 100 mL of demineralised water. Psyllium husk Fiber and Flax seed fibers were added 0.5 gm to 100 ml of demineralised water due to high gelling property. The pH was adjusted to 7.0±0.2 and autoclaved at 121°C for 20 min. After sterilization, oxygen reducing enzyme Oxyrase (Oxyrase® for Broth, Oxyrase, Inc, Mansfield, OH, USA) was added to each flask, to induce anaerobic conditions. Five percent of overnight grown Bacillus coagulans MTCC 5856 culture was inoculated to all the flasks and incubated at 37°C with gentle shaken rpm for 24 h. The bottles were tightly closed and sealed with parafilm to maintain anaerobic conditions generated by the enzyme supplement. pH values at 0 h of incubation and after fermentation (24 h) were also recorded. One ml of copper sulphate (10g/L) was added to each sample to inhibit further microbial growth (Sigma, St. Louis, MO, USA). The analysis of short chain fatty acids in the aforesaid fermentation samples was done adopting the following parameters.
Reagents
  1. 1. Diethyl Ether (AR Grade)
  2. 2. H2SO4
  3. 3. RO Water
  4. 4. Sodium Chloride (AR Grade)
Chromatographic conditions
Oven:
Rate Temperature Hold time
Initial 80 ° C 1.00 minute
8° C/minute 200° C 2.00 minute
  1. 1. Post run temperature 220°C
  2. 2. Post Time 5.0 min
  3. 3. Run time 18.00 min
Inlet
Injection Volume 1 µl
Temperature 250°C
Mode Split
Split ratio 10:1
Column
  1. 1. DB-FFAP (Terephthalic acid modified poly ethylene Glycol)
  2. 2. Dimensions: 30.00m X 250.00 mm X 0.25 µm.
  3. 3. Carrier gas : Nitrogen
  4. 4. Flow: 1.0 ml / min
Detector
1. Type FID
2. Temperature 350°C
3. Hydrogen Flow 30.0ml/min
4. Air flow 300.0 ml/min
5. Make Up Flow 5.0 ml/min
Standard solution preparation
100.0 mg of each of Fatty acid standard (Acetic acid, Propionic acid and Butyric acid) was weighed accurately in a 100ml volumetric flask & dissolved in 50.0 mL of water and made up to the mark with water and mixed well (Stock solution). Further, 10.0 mL of the stock solution was diluted to 100.0 mL with water and mixed well to get standard solution. 5 mL of standard solution was subjected to extraction as described herein below.
  1. 1. Taken 5ml of Standard solution / sample.
  2. 2. To Standard solution added 5ml of water with vortexing for 0.5 min.
  3. 3. Adjusted pH to 1-1.5 with 3M H2SO4 with vortexing for 0.5 min.
  4. 4. Kept diethyl ether in -20°C up to 1hr before adding to the sample /Working Standard.
  5. 5. Added 10ml of diethyl ether with vortexing for 1 min.
  6. 6. Added 4g of Sodium Chloride with vortexing for 1 min.
  7. 7. Centrifuged to separate Water Layer & Diethyl Layer
  8. 8. Transferred 1.0 mL of Diethyl Ether layer in GC Vial & Injected.
Procedure:
1 µl each of extracted standard solution was injected into the chromatograph in triplicate and recorded the responses of major peaks due to Acetic acid, Propionic acid and Butyric acid. The % Relative Standard Deviation for area of peaks due to Acetic acid, Propionic acid and Butyric acid in triplet injections should not be more than 2.0 %. Injected 1.0 µl each of extracted sample solution into the chromatograph. The content of Acetic acid, Propionic acid and Butyric acid was calculated as follows.
The results of the chromatographic analysis are presented in Fig. 4. In Fig. 4 "SCFA" means "Total Short Chain Fatty Acids", "Plant Fibers + B. coagulans MTCC 5856" means "Plant Based Natural Fibers (as sole nutritional source)", and "Plant Fibers + MRSD + B. coagulans MTCC 5856" means "Plant Based Natural Fibers along with MRS Media devoid of dextrose".
While the invention has been described with reference to a preferred embodiment, it is to be clearly understood by those skilled in the art that the invention is not limited thereto. Rather, the scope of the invention is to be interpreted only in conjunction with the appended claims.

Claims (3)

  1. A method of increasing the viable colony count of Bacillus coagulans MTCC 5856 said method comprising step of growing Bacillus coagulans MTCC 5856 in the presence of natural plant fibers selected from the group consisting of Trigonella foenum-graecum (fenugreek) seed fibers, Lycium barbarum seed fibers, Linum usitatissimum (Flax) seed fibers, Cocos nucifera (Coconut) fibers, Zingiber officinale (Ginger) rhizome fibers, Emblica officinalis (Amla) fruit fibers, Plantago ovata (Psyllium) fibers and Vaccinium oxycoccos (Cranberry) seed fibers, wherein the method is not a method for treatment of the human or animal body by therapy.
  2. Combination of natural plant fibers and Bacillus coagulans MTCC 5856, wherein Bacillus coagulans MTCC 5856 is co-cultured with the natural plant fibers selected from the group consisting of Trigonella foenum-graecum (fenugreek) seed fibers, Lycium barbarum seed fibers, Linum usitatissimum (Flax) seed fibers, Cocos nucifera (Coconut) fibers, Zingiber officinale (Ginger) rhizome fibers, Emblica officinalis (Amla) fruit fibers, Plantago ovata (Psyllium) fibers and Vaccinium oxycoccos (Cranberry) seed fibers for use in the treatment of a subject affected by pathogenic Gram negative bacteria by bringing into contact said Gram negative bacteria with said Bacillus coagulans, wherein said Gram negative bacteria are E. coli.
  3. A method of producing short chain fatty acids by co-culturing Bacillus coagulans MTCC 5856 with natural plant fibers selected from the group consisting of Trigonella foenum-graecum (fenugreek) seed fibers, Lycium barbarum seed fibers, Linum usitatissimum (Flax) seed fibers, Cocos nucifera (Coconut) fibers, Zingiber officinale (Ginger) rhizome fibers, Emblica officinalis (Amla) fruit fibers, Plantago ovata (Psyllium) fibers and Vaccinium oxycoccos (Cranberry) seed fibers.
HK17106902.5A 2014-08-29 2015-08-29 Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof HK1233174B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462043599P 2014-08-29
US201462063453P 2014-10-14

Publications (2)

Publication Number Publication Date
HK1233174A1 HK1233174A1 (en) 2018-01-26
HK1233174B true HK1233174B (en) 2021-01-08

Family

ID=

Similar Documents

Publication Publication Date Title
EP3185877B1 (en) Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof
US10323227B2 (en) Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof
Zeaiter et al. Extraction and characterization of inulin‐type fructans from artichoke wastes and their effect on the growth of intestinal bacteria associated with health
Li et al. In-vitro digestion by simulated gastrointestinal juices of Lactobacillus rhamnosus cultured with mulberry oligosaccharides and subsequent fermentation with human fecal inocula
CN112544981A (en) Preparation method of sea-buckthorn probiotic microcapsules and sea-buckthorn probiotic microcapsule product prepared by same
KR20190072923A (en) Antioxidant and Immune-enhancing functional beverage and food composition comprising the extract of edible flowers fermented by lactic acid bacteria and preparation method of the same
CN103750102B (en) There is the composition and method of making the same containing blackberry, blueberry of function of reducing blood sugar
CN105685620A (en) Moringa oleifera oral liquid and preparation method thereof
KR101825064B1 (en) Method for manufacturing whole red ginseng powder and whole red ginseng concentrate for enabling intake of total red ginseng and maximizing digestion absorption of active ingredient through physical ultrafine pulverization
CN101904499B (en) Method for preparing probiotics and ginkgo pollen oral solution
CN110122868B (en) Stichopus japonicus enzyme, Stichopus japonicus enzyme beverage and preparation method
Ayimbila et al. Bioactive composition and modulatory effects of Hed-Tean-Rad Mushroom, Macrocybe crassa on gut microbiota
HK1233174B (en) Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof
HK1233174A1 (en) Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof
NZ748360A (en) Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof
CN112957403A (en) Medicinal bacterium composition for treating alcoholic liver injury and preparation method and application thereof
CN114600986A (en) Hypoglycemic effect of kombucha prepared by direct-throwing starter and kombucha
KR20170082286A (en) Methods for preparing fermented red ginseng powder dispersion wih maximized uptake ratio not containing emulsifier
CN117143795B (en) Method for improving oxidation resistance and promoting proliferation of probiotics and composition thereof
KR102202092B1 (en) Weissella koreensis nd824 strain having improved productivity of ornithine and composition comprisingng the same
CN110755439B (en) A kind of polysaccharide prebiotic and its preparation method and application
CN112155199B (en) Capsule containing Ganoderma lucidum sporophore spore powder fermentation liquid and preparation method thereof
Suh et al. patients following surgical
Narayanan Merging the Various Benefits of the Fermentation of the Rice & Rice Products; a Deep Dive into Its Nutritional Benefits, Physiological Activities, and Functional Potentials-A Review
CN117770438A (en) Preparation method of toona sinensis bud powder with blood sugar reducing function